Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ergo Bioscience
AddedFeb 16, 2024
UpdatedJun 18, 2026
Ergo Bioscience

Ergo Bioscience

Seed

Ergo Bioscience: A biotech start-up revolutionizing the food sector with precise, eco-friendly fermentation solutions.

HQ
Wilmington, DE, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Ergo Bioscience, founded with the mission to revolutionize the food sector, focuses on the precise fermentation of plant cells to produce essential and intricate animal proteins. The company aims to provide innovative and environmentally friendly solutions by leveraging science and nature. Ergo Bioscience's core products include plant-based myoglobin and casein, which are critical for replicating the flavors, aroma, color, and texture of animal-origin foods. Their market focus is on transforming the food industry by offering sustainable alternatives to traditional animal proteins.

Notable affiliated individuals and investors include experts in biotechnology and sustainable food production, although specific names are not provided. Key achievements of Ergo Bioscience include developing cutting-edge fermentation techniques that replicate animal proteins without the need for animals, thus significantly reducing environmental impact. The overall impact of Ergo Bioscience is its contribution to a more sustainable and eco-friendly food industry, addressing the growing demand for plant-based protein alternatives while maintaining the sensory qualities of animal-derived foods.

Ergo Bioscience - Similar Companies

Better Meat logo

Better Meat

bettermeat.co

Air Protein logo

Air Protein

airprotein.com

The Every Company logo

The Every Company

NovoNutrients logo

NovoNutrients

novonutrients.com

Fybraworks Foods logo

Fybraworks Foods

fybrawork.com

Afineur logo

Afineur

afineur.com

Propel Foods logo

Propel Foods

propelfoods.com

Change Foods logo

Change Foods

changefoods.com

De Novo Foodlabs logo

De Novo Foodlabs

denovofoodlabs.com

Perfect Day logo

Perfect Day

perfectday.com

Plasma Nutrition logo

Plasma Nutrition

becomeio.com

Simply Foods logo

Simply Foods

newagemeats.com

Ecto logo

Ecto

ecto.com

Motif logo

Motif

madewithmotif.com

Grounded Foods logo

Grounded Foods

Ergo Bioscience - Quick Facts

Who are Ergo Bioscience's competitors?

Companies similar to Ergo Bioscience include Better Meat, Air Protein, The Every Company and NovoNutrients.

When was Ergo Bioscience founded?

Ergo Bioscience was founded in 2020.

Where is Ergo Bioscience's headquarters located?

Ergo Bioscience's headquarters is located in Wilmington, DE, US.

When was Ergo Bioscience's last funding round?

Ergo Bioscience's most recent funding round was for $1.5M (USD) in September 2023.

How much has Ergo Bioscience raised to-date?

As of Sep 20, 2023, Ergo Bioscience has raised a total of $1.7M (USD).

How many employees does Ergo Bioscience have?

Ergo Bioscience has 11 employees as of Feb 4, 2024.

Ergo Bioscience - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • Fermentation
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Plant Proteins
Tags
  • Foodtech
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
  • 311100Animal Food Manufacturing
  • 311110Animal Food Manufacturing
SIC
  • 2000Food And Kindred Products
  • 2040Grain Mill Products
  • 2048Prepared Feeds And Feed Ingredients For Animals And Fowls, Except Dog And Cat